HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis.

AbstractOBJECTIVE:
To investigate the effect of a single intravenous treatment with glucocorticoids (GC) encapsulated in long-circulating PEG-liposomes on both joint inflammation and cartilage destruction and to investigate the phenomenon of selective homing of these liposomes in the inflamed synovium.
METHODS:
Mice with collagen type II-induced arthritis (CIA) were intravenously treated with liposomal and free prednisolone phosphate (PLP) a few days after the first signs of the disease. Joint inflammation was scored during 1 week after treatment, after which sections of the knee joints were prepared for assessment of cartilage damage. In addition, arthritic mice were treated with liposomes containing colloidal gold. 24 hours after injection, knee joint sections were prepared in which the location of liposomes was visualised.
RESULTS:
Treatment of CIA with 10 mg/kg liposomal PLP resulted in a strong and lasting resolution of joint inflammation. 10 mg/kg free PLP only became slightly effective after repeated daily injections. Although joint inflammation recurred 1 week after treatment with liposomal PLP, knee joint sections prepared at this time indicated that the cartilage damage was still reduced. Localisation of gold labelled liposomes in the inflamed joints was seen in the proximity of blood vessels, in the cellular infiltrate, but mainly in the synovial lining. Unaffected joints did not take up liposomes.
CONCLUSIONS:
By using the property of long-circulating liposomes to target the synovial lining selectively in inflamed joints, the anti-inflammatory activity of GC can be greatly increased, showing also the beneficial effect of reduced cartilage destruction.
AuthorsJ M Metselaar, W B van den Berg, A E M Holthuysen, M H M Wauben, G Storm, P L E M van Lent
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 63 Issue 4 Pg. 348-53 (Apr 2004) ISSN: 0003-4967 [Print] England
PMID15020326 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Liposomes
  • prednisolone phosphate
  • Prednisolone
Topics
  • Animals
  • Anti-Inflammatory Agents (administration & dosage)
  • Arthritis, Experimental (drug therapy, pathology)
  • Glucocorticoids (administration & dosage)
  • Hindlimb
  • Injections, Intravenous
  • Joints (drug effects, pathology)
  • Liposomes
  • Male
  • Mice
  • Mice, Inbred DBA
  • Prednisolone (administration & dosage, analogs & derivatives)
  • Spleen (pathology)
  • Synovial Membrane (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: